<DOC>
	<DOC>NCT02887495</DOC>
	<brief_summary>The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.</brief_summary>
	<brief_title>The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)</brief_title>
	<detailed_description />
	<mesh_term>Scleroderma, Systemic</mesh_term>
	<mesh_term>Scleroderma, Diffuse</mesh_term>
	<mesh_term>Scleroderma, Localized</mesh_term>
	<criteria>Age &gt;18 years Able to give informed consent. Diagnosed with scleroderma or with positive autoantibodies &lt; 18 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>biorepository</keyword>
</DOC>